Fundación Instituto Valenciano de Oncología (IVO)

Valencia 46009

1 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Gastric Cancer, Head and Neck Squamous Cell Carcinoma, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Recurrent Breast Cancer

Studies at this site

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer — Recruiting now
• Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination — Running, not enrolling